Abstract
The cyclooxygenase enzyme system produces eicosanoids which mediate many important physiological and pathological functions. Experimental and clinical data suggest a role for this enzyme system in the pathogenesis of allergic inflammation and asthma. This article focuses on the function of this pathway in the lung, reviews evidence implicating the involvement of this pathway in asthma and allergic airway inflammation, and discusses implications for the treatment of asthmatics with cyclooxygenase inhibitors.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Arachidonic Acid / metabolism
-
Asthma / drug therapy
-
Asthma / etiology*
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / pharmacology*
-
Cyclooxygenase Inhibitors / therapeutic use
-
Humans
-
Hypersensitivity / drug therapy
-
Hypersensitivity / etiology*
-
Inflammation / drug therapy
-
Inflammation / etiology
-
Isoenzymes / metabolism
-
Lung / enzymology
-
Lung / metabolism
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases / metabolism*
-
Prostaglandins / biosynthesis
-
Prostaglandins / metabolism
-
Receptors, Prostaglandin / metabolism
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Membrane Proteins
-
Prostaglandins
-
Receptors, Prostaglandin
-
Arachidonic Acid
-
Cyclooxygenase 1
-
Cyclooxygenase 2
-
PTGS1 protein, human
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases